SYNPR | Synaptoporin | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
HRC | Histidine rich calcium binding protein | Predicted secreted proteins
| | | | | Group enriched |
TTN | Titin | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
CKMT2 | Creatine kinase, mitochondrial 2 (sarcomeric) | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Group enriched |
MYPN | Myopalladin | Disease related genes
| | | | | Group enriched |
MYO18B | Myosin XVIIIB | | | | | | Group enriched |
ADPRHL1 | ADP-ribosylhydrolase like 1 | | | | | | Group enriched |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MYH7 | Myosin, heavy chain 7, cardiac muscle, beta | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Group enriched |
LMOD2 | Leiomodin 2 (cardiac) | Cytoskeleton related proteins
| | | | | Group enriched |
SRL | Sarcalumenin | Predicted secreted proteins
| | | | | Group enriched |
UNC45B | Unc-45 homolog B (C. elegans) | | | | | | Group enriched |
MYL2 | Myosin, light chain 2, regulatory, cardiac, slow | Candidate cardiovascular disease genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
SYNPO2L | Synaptopodin 2-like | Cytoskeleton related proteins Plasma proteins
| | | | | Group enriched |
CSRP3 | Cysteine and glycine-rich protein 3 (cardiac LIM protein) | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
TRDN | Triadin | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
APOBEC2 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 | | | | | | Group enriched |
LDB3 | LIM domain binding 3 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
MYOM1 | Myomesin 1 | | | | | | Group enriched |
MYOM2 | Myomesin 2 | | | | | | Group enriched |
RBFOX1 | RNA binding protein, fox-1 homolog (C. elegans) 1 | | | | | | Group enriched |
XIRP1 | Xin actin-binding repeat containing 1 | | | | | | Group enriched |
ANKRD2 | Ankyrin repeat domain 2 (stretch responsive muscle) | | | | | | Group enriched |
TCAP | Titin-cap | Disease related genes
| | | | | Group enriched |
TNNC1 | Troponin C type 1 (slow) | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
PPAPDC3 | Phosphatidic acid phosphatase type 2 domain containing 3 | Predicted membrane proteins
| | | | | Group enriched |
MB | Myoglobin | Candidate cardiovascular disease genes Plasma proteins
| | | | | Group enriched |
MYL3 | Myosin, light chain 3, alkali; ventricular, skeletal, slow | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Group enriched |
PDE4DIP | Phosphodiesterase 4D interacting protein | Cancer-related genes Disease related genes
| | | | | Group enriched |
FABP3 | Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | Candidate cardiovascular disease genes Plasma proteins
| | | | | Group enriched |
CAV3 | Caveolin 3 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
HHATL | Hedgehog acyltransferase-like | Predicted membrane proteins
| | | | | Group enriched |
MLF1 | Myeloid leukemia factor 1 | Cancer-related genes Disease related genes
| | | | | Group enriched |
MURC | Muscle-related coiled-coil protein | | | | | | Group enriched |
SH3BGR | SH3 domain binding glutamic acid-rich protein | | | | | | Group enriched |
SPHKAP | SPHK1 interactor, AKAP domain containing | | | | | | Group enriched |
TXLNB | Taxilin beta | | | | | | Group enriched |
TYRP1 | Tyrosinase-related protein 1 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
NT5C1A | 5'-nucleotidase, cytosolic IA | Enzymes
| | | | | Group enriched |
POPDC3 | Popeye domain containing 3 | Predicted membrane proteins
| | | | | Group enriched |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins
| | | | | Group enriched |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
FAM69C | Family with sequence similarity 69, member C | | | | | | Group enriched |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
MYO18A | Myosin XVIIIA | Cytoskeleton related proteins Plasma proteins
| | | | | Group enriched |
S100A1 | S100 calcium binding protein A1 | Cancer-related genes Plasma proteins
| | | | | Group enriched |
SGCA | Sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) | Cytoskeleton related proteins Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
SGCG | Sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |